| 000 | 01484 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513113922.0 | ||
| 264 | 0 | _c19970610 | |
| 008 | 199706s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVillani, F | |
| 245 | 0 | 0 |
_aOral doxophylline in patients with chronic obstructive pulmonary disease. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cMar 1997 |
||
| 300 |
_a107-11 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
| 650 | 0 | 4 |
_aAntitussive Agents _xblood |
| 650 | 0 | 4 | _aBlood Gas Analysis |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForced Expiratory Flow Rates _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Diseases, Obstructive _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRespiratory Function Tests |
| 650 | 0 | 4 | _aSpirometry |
| 650 | 0 | 4 |
_aTheophylline _xanalogs & derivatives |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDe Maria, P | |
| 700 | 1 | _aRonchi, E | |
| 700 | 1 | _aGalimberti, M | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 35 _gno. 3 _gp. 107-11 |
|
| 999 |
_c9072811 _d9072811 |
||